Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SREK1IP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NCSTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TSHZ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIRAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERVK3-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CERS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H4I - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC283585 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C21orf33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRCH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C12orf65 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THOP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00536 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on